Welcome to our dedicated page for Bigcommerce Holdings SEC filings (Ticker: BIGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Subscription versus transaction revenue for an open SaaS commerce platform like BigCommerce Holdings, Inc. can be buried in hundreds of pages of disclosures. Tracking merchant growth, churn and expansion across regions—while also monitoring executive trades—quickly becomes a full-time job. BigCommerce Holdings SEC filings explained simply is what most investors really need.
Stock Titan’s AI-powered engine turns that deep dive into a five-minute read. Search phrases investors actually use—“BigCommerce Holdings quarterly earnings report 10-Q filing� or “BigCommerce Holdings annual report 10-K simplified”—surface instant summaries, red-lined year-over-year changes and key SaaS metrics. AG˹ٷ-time alerts ping you the moment “BigCommerce Holdings Form 4 insider transactions real-time� hit EDGAR, so no trade goes unnoticed.
- 10-K & 10-Q: revenue mix, ARR, churn, partner ecosystem growth—fueling your “BigCommerce Holdings earnings report filing analysis�.
- 8-K: partnership launches and outages—“BigCommerce Holdings 8-K material events explained�.
- Proxy (DEF 14A): “BigCommerce Holdings proxy statement executive compensation� with detailed stock-based pay tables.
- Form 4: “BigCommerce Holdings executive stock transactions Form 4� to spot sentiment shifts.
Whether you need “BigCommerce Holdings insider trading Form 4 transactions� before product announcements or just want an at-a-glance view of cash burn trends, our platform delivers. The AI extracts ARR, average revenue per account and deferred revenue footnotes, benchmarks R&D spending, and highlights geographic expansion so you can compare peers in minutes. In short, understanding BigCommerce Holdings SEC documents with AI means spending less time parsing legal text and more time making informed decisions.
Form 4 filing overview: On 06/30/2025, MAIA Biotechnology, Inc. (ticker MAIA) granted director Cristian Luput a package of stock options under the company’s 2021 Equity Incentive Plan.
- Options granted: 21,350 options to purchase common shares.
- Exercise price: $1.80 per share.
- Vesting schedule: 100% vested immediately on the grant date.
- Expiration: 06/30/2035 (10-year term).
- Post-transaction holdings: Luput now holds 21,350 derivative securities directly.
No non-derivative share transactions were reported, and the filing was made individually by the director. The grant represents routine equity compensation designed to align director incentives with shareholder value, but it modestly increases the company’s fully diluted share count.
Hovnanian Enterprises, Inc. (HOV) � Form 4 insider transaction
Director Edward A. Kangas reported the sale of 5,500 shares of the company’s Class A common stock on 30 Jun 2025 at a weighted average price of $107.121 per share. Following the disposition, his direct holdings declined from 10,838 to 5,338 shares. No derivative security transactions were reported, and no 10b5-1 trading plan was indicated.